Sökresultat - Xianmei Luo

Cost-effectiveness of pembrolizumab plus chemotherapy vs. chemotherapy as first-line treatment for advanced biliary tract cancer in China and the US av Xianmei Luo, Xianmei Luo, Tingting Cai, Tingting Cai, Jinyan Wu, Xingyu Li, Xingyu Li, Xiaofan Wang, Xiaofan Wang, Haiying Ma, Haiying Ma

Connect to this object online.